Aminomethylbenzoate esters of chloramphenicol as a novel prodrug type for parenteral administration
- 31 March 1991
- journal article
- Published by Elsevier in International Journal of Pharmaceutics
- Vol. 70 (1-2) , 137-146
- https://doi.org/10.1016/0378-5173(91)90173-l
Abstract
No abstract availableKeywords
This publication has 15 references indexed in Scilit:
- Design of a water-soluble, solution-stable and biolabile prodrug of metronidazole for parenteral administration: N-substituted aminomethylbenzoate estersInternational Journal of Pharmaceutics, 1990
- A novel solution-stable, water-soluble prodrug type for drugs containing a hydroxyl or an NH-acidic groupJournal of Medicinal Chemistry, 1989
- Clinical Pharmacokinetics of Chloramphenicol and Chloramphenicol SuccinateClinical Pharmacokinetics, 1984
- Prodrugs as drug delivery systems XXVII. Chemical stability and bioavailability of a water-soluble prodrug of metronidazole for parenteral administrationInternational Journal of Pharmaceutics, 1984
- Pharmacokinetics of intravenous chloramphenicol sodium succinate in adult patients with normal renal and hepatic functionJournal of Pharmacokinetics and Biopharmaceutics, 1982
- High-pressure liquid chromatographic assay for chloramphenicol, chloramphenicol-3-monosuccinate, and chloramphenicol-1-monosuccinateJournal of Pharmaceutical Sciences, 1980
- Rearrangement of chloramphenicol-3-monosuccinateJournal of Pharmaceutical Sciences, 1980
- The Kinetics of Degradation of Chloramphenicol in SolutionJournal of the American Pharmaceutical Association (Scientific ed.), 1954
- The Kinetics of Degradation of Chloramphenicol in SolutionJournal of the American Pharmaceutical Association (Scientific ed.), 1954
- The Kinetics of Degradation of Chloramphenicol in SolutionJournal of the American Pharmaceutical Association (Scientific ed.), 1953